These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 9080122

  • 1. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.
    Nielsen LL, Dell J, Maxwell E, Armstrong L, Maneval D, Catino JJ.
    Cancer Gene Ther; 1997; 4(2):129-38. PubMed ID: 9080122
    [Abstract] [Full Text] [Related]

  • 2. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
    Harris MP, Sutjipto S, Wills KN, Hancock W, Cornell D, Johnson DE, Gregory RJ, Shepard HM, Maneval DC.
    Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
    [Abstract] [Full Text] [Related]

  • 3. In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts.
    Song K, Cowan KH, Sinha BK.
    Oncol Res; 1999; 11(3):153-9. PubMed ID: 10527075
    [Abstract] [Full Text] [Related]

  • 4. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL, Lipari P, Dell J, Gurnani M, Hajian G.
    Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
    Li PX, Ngo D, Brade AM, Klamut HJ.
    Cancer Gene Ther; 1999 Apr; 6(2):179-90. PubMed ID: 10195885
    [Abstract] [Full Text] [Related]

  • 7. Adenovirus-p53-mediated gene therapy of anaplastic large cell lymphoma with t(2;5) in a nude mouse model.
    Turturro F, Heineke HL, Drevyanko TF, Link CJ, Seth P.
    Gene Ther; 2000 Jun; 7(11):930-3. PubMed ID: 10849552
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model.
    Li Z, Rakkar A, Katayose Y, Kim M, Shanmugam N, Srivastava S, Moul JW, McLeod DG, Cowan KH, Seth P.
    Gene Ther; 1998 May; 5(5):605-13. PubMed ID: 9797864
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
    Xie Y, Gilbert JD, Kim JH, Freytag SO.
    Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364
    [Abstract] [Full Text] [Related]

  • 10. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M, Sasaki Y, Suzuki H, Mita H, Imai K, Shinomura Y, Tokino T.
    Clin Cancer Res; 2009 Jun 01; 15(11):3725-32. PubMed ID: 19458054
    [Abstract] [Full Text] [Related]

  • 11. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
    Ahn WS, Bae SM, Lee KH, Lee JM, Namkoong SE, Chun HJ, Kim CK, Kim YW.
    Gynecol Oncol; 2004 Feb 01; 92(2):611-21. PubMed ID: 14766255
    [Abstract] [Full Text] [Related]

  • 12. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ, Stilwell A, Dong YB, Yang HL, Wong SL, Wrightson WR, Martin RC, McMasters KM.
    Cancer Gene Ther; 2002 May 01; 9(5):453-63. PubMed ID: 11961668
    [Abstract] [Full Text] [Related]

  • 13. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF, Xie L, McDonald M, DiGiacomo R, Chang A, Gurnani M, Shi B, Liu S, Indelicato SR, Hutchins B, Nielsen LL.
    Cancer Gene Ther; 2000 Nov 01; 7(11):1469-80. PubMed ID: 11129289
    [Abstract] [Full Text] [Related]

  • 14. The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer.
    Rizk NP, Chang MY, El Kouri C, Seth P, Kaiser LR, Albelda SM, Amin KM.
    Cancer Gene Ther; 1999 Nov 01; 6(4):291-301. PubMed ID: 10419047
    [Abstract] [Full Text] [Related]

  • 15. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.
    Parker LP, Wolf JK, Price JE.
    Ann Clin Lab Sci; 2000 Oct 01; 30(4):395-405. PubMed ID: 11045764
    [Abstract] [Full Text] [Related]

  • 16. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
    Ji L, Fang B, Yen N, Fong K, Minna JD, Roth JA.
    Cancer Res; 1999 Jul 15; 59(14):3333-9. PubMed ID: 10416589
    [Abstract] [Full Text] [Related]

  • 17. In vivo studies of adenovirus-based p53 gene therapy for ovarian cancer.
    von Gruenigen VE, Santoso JT, Coleman RL, Muller CY, Miller DS, Mathis JM.
    Gynecol Oncol; 1998 Jun 15; 69(3):197-204. PubMed ID: 9648587
    [Abstract] [Full Text] [Related]

  • 18. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer.
    Spitz FR, Nguyen D, Skibber JM, Cusack J, Roth JA, Cristiano RJ.
    Anticancer Res; 1996 Jun 15; 16(6B):3415-22. PubMed ID: 9042200
    [Abstract] [Full Text] [Related]

  • 19. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
    Komata T, Kondo Y, Koga S, Ko SC, Chung LW, Kondo S.
    Gene Ther; 2000 Dec 15; 7(24):2071-9. PubMed ID: 11223987
    [Abstract] [Full Text] [Related]

  • 20. Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo.
    Riccioni T, Cirielli C, Wang X, Passaniti A, Capogrossi MC.
    Gene Ther; 1998 Jun 15; 5(6):747-54. PubMed ID: 9747454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.